+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nichi Iko Pharmaceutical Co Ltd - logo

Nich-Iko is a pharmaceutical company that manufactures, sells and distributes products for circulatory, digestive, respiratory, central and peripheral nervous systems and others. It was founded in 1965 and it is headquartered in Tokyo. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005.

Remicade Biosimilar Global Market Report 2024 - Product Thumbnail Image

Remicade Biosimilar Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Gemcitabine Hydrochloride Market 2024-2028 - Product Thumbnail Image

Gemcitabine Hydrochloride Market 2024-2028

  • Report
  • July 2024
  • 132 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Generic Injectables Market (2022 Edition) - Analysis By Molecule Type, (Small, Large), Therapeutic Area, Container Type, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2022-2027) - Product Thumbnail Image

Generic Injectables Market (2022 Edition) - Analysis By Molecule Type, (Small, Large), Therapeutic Area, Container Type, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2022-2027)

  • Report
  • February 2022
  • 240 Pages
  • Global
From
Generic Oncology Sterile Injectable Global Market Report 2024 - Product Thumbnail Image

Generic Oncology Sterile Injectable Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Anti-Asthmatics and COPD Drugs Global Market Report 2024 - Product Thumbnail Image

Anti-Asthmatics and COPD Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Branded Generics Market by Product, Drug Type, Route of Administration, Indication, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Branded Generics Market by Product, Drug Type, Route of Administration, Indication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 195 Pages
  • Global
From
Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 145 Pages
  • Global
From
Heparin Market 2024-2028 - Product Thumbnail Image

Heparin Market 2024-2028

  • Report
  • November 2023
  • 165 Pages
  • Global
From
Trastuzumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Trastuzumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Ulcerative Colitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 779 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Rituximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Rituximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Headache Disorders Global Market Report 2024 - Product Thumbnail Image

Headache Disorders Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Darbepoetin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Darbepoetin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 628 Pages
  • Global
From
Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • March 2019
  • 220 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Loading Indicator